GLOBAL RESEARCH ARCHIVE
Best Smidcap Ideas: Life Is Still Good At Globe
Research evidence excerpt
Best Smidcap Ideas: Life Is Still Good At Globe
TD Cowen Globe Life
Global Research June 23, 2026
Business Model Supports Sustained Low-Double-Digit EPS Growth
GL is on track to achieve sustained low-double-digit EPS growth over time, supported by mid-
single-digit premium growth, growth in net investment income, and active share repurchases,
with expense leverage providing an additional tailwind.
Management reinforced this view during recent meetings post 1Q26 earnings, noting that
normalized EPS has grown at a roughly 11.5% annual rate over the past three years, excluding
one-time assumption updates.
While sustained low-double-digit growth would be modestly above the company's 8-9%
historical growth rate, the underlying business model supports this outlook (aided by recent
improvements in free cash flow and interest rates).
GL serves lower-middle and middle-income U.S. households, a large and often underserved
market where many life insurers have limited presence. Moreover, the company's predominantly
exclusive distribution model, with much of its sales through exclusive agents, reduces price
competition at the point of sale and has historically supported consistent mid-single-digit or
greater sales and premium growth.
Just as important, GL achieves this growth with below-peer underwriting risk, balance sheet
intensity and market sensitivity. On the life side, the company focuses on low face value, whole
life and term products, which carry less severity risk and require less reinsurance. On the
health side, GL's portfolio consists primarily of Medicare Supplement and supplemental health
products, which have historically generated relatively stable underwriting margins and can be
re-priced quickly.
Fundamentals Remain Favorable
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer